ABT Stock Up on First Successful LBBAP Procedures With AVEIR Pacemaker
Portfolio Pulse from
Abbott Laboratories (ABT) has successfully completed the world's first leadless pacing procedures in the left bundle branch of the heart using its AVEIR pacemaker. This milestone could enhance Abbott's position in the cardiac device market.
December 18, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Abbott Laboratories has completed the first successful leadless pacing procedures in the left bundle branch using its AVEIR pacemaker. This advancement could strengthen Abbott's market position in cardiac devices.
The successful completion of the first leadless pacing procedures in the left bundle branch using the AVEIR pacemaker is a significant technological advancement. This could lead to increased adoption of Abbott's cardiac devices, potentially boosting sales and improving market share.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100